Iranian Helps Develop  Ultra-Sensitive Nanosensor
Economy, Sci & Tech

Iranian Helps Develop Ultra-Sensitive Nanosensor

An Iranian scientist, Nima Sharifi, along with his colleagues at US Case Western University, opened the door for a new detection method that allows doctors to diagnose patients with certain cancers far earlier than possible today.
The researchers have developed an optical sensor that they claim is one million times more sensitive than the best available.
The research was published online in the journal Nature Materials.
The nanosensor, which fits in the palm of a hand, acts like a biological sieve, isolating a small protein molecule weighing less than 800 quadrillionths of a nanogram from an extremely diluted solution.
"This biosensing platform may help unlock the next era of initial cancer detection," said lead researcher Giuseppe Strangi, professor of physics at Case Western Reserve University.
"The prognosis of many cancers depends on the stage of the cancer at diagnosis," Strangi said.
"Very early, most circulating tumor cells express proteins of a very low molecular weight, less than 500 Daltons (standard unit for atomic mass)."
These proteins are usually too small and in too low a concentration to detect with current test methods, yielding false negative results. "With this platform, we've detected proteins of 244 Daltons, which should enable doctors to detect cancers earlier—we don't know how much earlier yet," he said.
The researchers believe the sensing technology will also be useful in diagnosing and monitoring other diseases as well.
Strangi and Nima Sharifi, also from Case Western Reserve University, have begun testing the sensor with proteins related to prostate cancers.
Sharifi said high sensitivity detection of cancer-specific proteins in blood should enable the detection of tumors when they are at an earlier disease stage.
"This new sensing technology may help us not only detect cancers, but what subset of cancer, what's driving its growth and spread and what it's sensitive to," he said.
"The sensor, for example, may help us determine markers of aggressive prostate cancers, which require treatments, or indolent forms that don't."
Strangi's lab is working with other oncologists worldwide to test the device and begin moving the sensor toward clinical use.


Short URL : http://goo.gl/MsBIqr
  1. http://goo.gl/zJ0Deo
  • http://goo.gl/01wfKc
  • http://goo.gl/RrdA4R
  • http://goo.gl/wCdHga
  • http://goo.gl/kQhyGu

You can also read ...

VDMA Backs Iran Trade
Germany’s plastics and rubber machinery trade association,...
Musk Bid for Tesla Still Murky
Tesla Inc’s board named a special committee of three directors...
Equity-Based Sukuk Return to Iran Capital Market
The government is set to clear part of its debt to Social...
S. Korea Bans Recalled BMWs Over Fire Fears
The South Korean government has said it will ban about 20,000...
New Forex Initiative Unable to Tip Scales
The new forex initiative has only managed to fix major policy...
Central Bank of Iran Against Market Intervention
Central Bank of Iran's Governor Abdolnasser Hemmati said the...
Over €81m Worth of Airport Equipment Purchased  Post JCPOA
Iran Airports & Air Navigation Company, an arm of the...
Tehran Home Rents Up 26.7 Percent in Q1
The average price of renting a residential unit in Tehran...